Bourdon, Audrey
François, Virginie
Zhang, Liwen
Lafoux, Aude
Fraysse, Bodvael
Toumaniantz, Gilles
Larcher, Thibaut
Girard, Tiphaine
Ledevin, Mireille
Lebreton, Cyrielle
Hivonnait, Agnès
Creismeas, Anna
Allais, Marine
Marie, Basile
Guguin, Justine
Blouin, Véronique
Remy, Séverine
Anegon, Ignacio
Huchet, Corinne
Malerba, Alberto
Kao, Betty
Le Heron, Anita
Moullier, Philippe
Dickson, George
Popplewell, Linda
Adjali, Oumeya
Montanaro, Federica
Le Guiner, Caroline http://orcid.org/0000-0002-6904-2300
Funding for this research was provided by:
DH | National Institute for Health Research
Muscular Dystrophy Association (# 513878)
Article History
Received: 12 April 2021
Revised: 9 December 2021
Accepted: 13 January 2022
First Online: 1 February 2022
Competing interests
: PM, GD and CLG are co-authors of a patent for systemic treatment of dystrophic pathologies (EP3044319A1, dated 27 June 2014). GD is an inventor on a PCT for production of large-sized micro-dystrophins in an AAV-based vector configuration (PCT/EP2016/060350, dated 17 May 2015). The remaining authors declare no competing financial interests.